Welcome to our dedicated page for Waystar Holding SEC filings (Ticker: WAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Healthcare payment platforms like Waystar generate disclosures packed with reimbursement rules, payer-mix tables, and subscription revenue details—information investors need yet struggle to find quickly. If you have ever searched for Waystar insider trading Form 4 transactions or wondered how to decode the company’s deferred revenue footnotes, you know the challenge.
Stock Titan solves this problem by pairing real-time EDGAR feeds with AI that turns complex jargon into clear insights. From a single dashboard you can:
- Track Waystar Form 4 insider transactions real-time and spot buying or selling before material events.
- Dive into each Waystar quarterly earnings report 10-Q filing with concise AI annotations on churn, average revenue per client, and regulatory exposure.
- Skim an AI-generated brief of the Waystar annual report 10-K simplified to understand revenue-cycle market share, cloud migration costs, and cybersecurity risks.
- Receive alerts when a Waystar 8-K material events explained post details new payer contracts or leadership changes.
Still asking, “How do I read Waystar’s proxy statement executive compensation?” or “Can I get a Waystar earnings report filing analysis without sifting through 200 pages?” Our platform answers both by extracting equity-based pay data and key performance metrics into digestible summaries. Whether you are monitoring Waystar executive stock transactions Form 4, comparing subscription growth across quarters, or simply understanding Waystar SEC documents with AI, Stock Titan equips you to make informed decisions faster.
Waystar Holding (WAY) filed a routine Form 4 for Chief Business Officer Eric L. Sinclair III. On 06/25/2025 he exercised 9,702 options at $4.14 (Code M) and immediately sold 9,702 shares at a weighted-average $40.2243 under a 10b5-1 plan adopted 02/19/2025.
The sale is valued at roughly $391 k, represents ~2 % of his 500,572-share position, and leaves him with 490,870 shares (including unvested RSUs). No other material changes were disclosed.
Eric L. Sinclair III (Ric), Chief Business Officer of Waystar Holding Corp (WAY), executed planned transactions under Rule 10b5-1(c) on June 20, 2025:
- Exercised 9,702 stock options at $4.14 per share
- Immediately sold 9,702 shares at weighted average price of $37.7877 (range: $37.65-$38.09)
- Post-transaction holdings: 490,870 shares (direct ownership, including unvested RSUs) and 126,118 stock options
These transactions were executed automatically according to a trading plan established on February 19, 2025. The significant spread between exercise price ($4.14) and sale price ($37.7877) resulted in substantial gains. The executive maintains a considerable equity position in the company following the transaction.
FAQ
What is the current stock price of Waystar Holding (WAY)?
What is the market cap of Waystar Holding (WAY)?
What does Waystar Holding Corp. do?
How does Waystar's platform improve healthcare payment processes?
What role does artificial intelligence play in Waystar's offerings?
Who are the primary customers of Waystar Holding Corp.?
What are the key benefits of using Waystar's software platform?
How does Waystar maintain its competitive edge in the healthcare IT market?
Does Waystar's platform support healthcare providers of all sizes?
How does Waystar contribute to improving revenue cycle management?
